title: [Molecular diagnostic testing in gliomas].
abstract: Glial tumours represent the majority of central nervous system tumours. Even though current therapy guidelines do not advocate the routine use of molecular markers for treatment decisions, the identification of prognostic markers and patient subgroups that may especially benefit from novel therapeutic options becomes increasingly important also outside the setting of clinical trials. This review summarizes methods and rationale for the use of the determination of 1p/19q loss, MGMT promoter methylation and tyrosine kinase receptor expression as diagnostic, prognostic and predictive markers in gliomas.
authors.affiliation: Institut für Neuropathologie, Universitätsklinikum Münster, Domagkstrasse 19, 48129, Münster, Deutschland. hasselblatt@uni-muenster.de
authors.forename: M
authors.initials: M
authors.lastname: Hasselblatt
mesh_terms: D014408:Biomarkers, Tumor / Q000235:genetics; D001932:Brain Neoplasms / Q000145:classification / Q000235:genetics* / Q000473:pathology; D002872:Chromosome Deletion; D002878:Chromosomes, Human, Pair 1 / Q000235:genetics; D002888:Chromosomes, Human, Pair 19 / Q000235:genetics; D005910:Glioma / Q000145:classification / Q000235:genetics* / Q000473:pathology; D006801:Humans; D025202:Molecular Diagnostic Techniques; D011237:Predictive Value of Tests; D011379:Prognosis
chemical_list: D014408:Biomarkers, Tumor
references.citation: J Clin Oncol. 1998 Oct;16(10):3310-5
references.pmid: 9779706
references.citation: Cancer Res. 1999 Feb 15;59(4):793-7
references.pmid: 10029064
references.citation: J Clin Oncol. 2007 Oct 20;25(30):4722-9
references.pmid: 17947719
references.citation: Science. 2007 Oct 12;318(5848):287-90
references.pmid: 17872411
references.citation: Acta Neuropathol. 2007 Aug;114(2):97-109
references.pmid: 17618441
references.citation: J Neurooncol. 2007 May;83(1):17-29
references.pmid: 17206475
references.citation: Neuro Oncol. 2006 Jan;8(1):27-37
references.pmid: 16443945
references.citation: Pediatr Blood Cancer. 2007 Apr;48(4):403-7
references.pmid: 16609952
references.citation: J Neurooncol. 2004 Mar-Apr;67(1-2):159-65
references.pmid: 15072463
references.citation: Appl Immunohistochem Mol Morphol. 2008 Jan;16(1):59-65
references.pmid: 18091318
references.citation: J Clin Oncol. 2008 Jan 10;26(2):271-8
references.pmid: 18182667
references.citation: J Clin Oncol. 2006 Jun 20;24(18):2715-22
references.pmid: 16782911
references.citation: N Engl J Med. 2005 Nov 10;353(19):2012-24
references.pmid: 16282176
references.citation: Anal Biochem. 2008 Jun 1;377(1):62-71
references.pmid: 18384736
references.citation: Int J Cancer. 2007 Dec 1;121(11):2458-64
references.pmid: 17691113
references.citation: J Mol Diagn. 2006 Sep;8(4):433-43
references.pmid: 16931583
references.citation: N Engl J Med. 2000 Nov 9;343(19):1350-4
references.pmid: 11070098
references.citation: J Neuropathol Exp Neurol. 2008 Jan;67(1):1-15
references.pmid: 18091559
references.citation: Acta Neuropathol. 2008 Feb;115(2):249-59
references.pmid: 17965865
references.citation: Science. 2006 May 26;312(5777):1175-8
references.pmid: 16728632
references.citation: Clin Cancer Res. 2004 Mar 15;10(6):1871-4
references.pmid: 15041700
references.citation: N Engl J Med. 2005 Mar 10;352(10):997-1003
references.pmid: 15758010
references.citation: Nat Rev Cancer. 2004 Apr;4(4):296-307
references.pmid: 15057289
references.citation: J Neuropathol Exp Neurol. 2007 Jun;66(6):545-51
references.pmid: 17549014
references.citation: J Mol Diagn. 2007 Jul;9(3):368-81
references.pmid: 17591937
references.citation: Am J Pathol. 1994 Nov;145(5):1175-90
references.pmid: 7977648
references.citation: Cancer. 1997 Apr 1;79(7):1381-93
references.pmid: 9083161
references.citation: Int J Cancer. 2005 Jan 20;113(3):379-85
references.pmid: 15455350
references.citation: J Clin Oncol. 2000 Feb;18(3):636-45
references.pmid: 10653879
references.citation: Lab Invest. 2007 Apr;87(4):392-7
references.pmid: 17260000
references.citation: Brain Pathol. 2008 Oct;18(4):520-32
references.pmid: 18400046
references.citation: J Clin Oncol. 2005 Dec 20;23(36):9359-68
references.pmid: 16361636